Rebeaud, J., Phillips, N. E., Thévoz, G., Vigne, S., Nassirnia, S., Gauthier-Jaques, A., . . . Pot, C. (2025). Blood metabolomics improves prediction of central nervous system damage in multiple sclerosis. Metabolomics, 21(5), 1. https://doi.org/10.1007/s11306-025-02315-2
Chicago Style (17th ed.) CitationRebeaud, Jessica, et al. "Blood Metabolomics Improves Prediction of Central Nervous System Damage in Multiple Sclerosis." Metabolomics 21, no. 5 (2025): 1. https://doi.org/10.1007/s11306-025-02315-2.
MLA (9th ed.) CitationRebeaud, Jessica, et al. "Blood Metabolomics Improves Prediction of Central Nervous System Damage in Multiple Sclerosis." Metabolomics, vol. 21, no. 5, 2025, p. 1, https://doi.org/10.1007/s11306-025-02315-2.
Warning: These citations may not always be 100% accurate.